Dr. Erin Baurle details the benefits of oncology counseling in helping patients with diagnosis disclosure and how to replace that familiar phrase of “let me know if you need anything” when offering to help a loved one with cancer.
With support from a $3.3 million federal grant Virginia Borges, MD, and Traci Lyons, PhD, will investigate how a molecule they’ve been studying for a decade is able to promote resistance to therapies for a major type of breast cancer in the hopes of determining how to switch off the molecule’s harmful interference.
At this years annual NCCN Conference in Orlando Dr. Flaig was excited to share the effectiveness of enfortumab vedotin, a new antibody drug conjugate that targets a particular or a bladder cancer cell and then delivers chemotherapy directly to that cell.
According to Dr. Chris Lieu, colon cancer is becoming the number one cancer-related issue in younger populations, with The American Cancer Society expecting more than 150,000 people to be diagnosed with colorectal cancer in 2024.
Dr. Baiyee discusses how her love of research has not only allowed her to improve patient care but also advance medicine. "It’s not just about taking care of patients, as far as their disease, but more holistically. My goal is to make this really, really hard experience as tolerable as possible and to offer them all the support we have"
Dr. Davila was recently awarded the Anschutz Acceleration Initiative Grant, he sits down to discuss his aim to enhance all forms of cellular immunotherapy has been awarded the Anschutz Acceleration Initiative Grant.
Dr. Messersmith discusses the ways in which a second opinion can boost patient confidence in the diagnosis and treatment recommendations.
The Thoracic Oncology Research Initiative (TORI), led by Dr. Sharon Pine, brings together investigators from multiple departments and centers across the CU Anschutz Medical Campus to advance lung cancer research.